Login to Your Account

Financings Roundup

Kythera, Intercept Dazzle with Dueling Initial Public Offerings

By Catherine Shaffer
Staff Writer

Friday, October 12, 2012
Intercept Pharmaceuticals Inc. and Kythera Biopharmaceuticals Inc. each priced initial public offerings (IPO) at the top of their ranges Thursday, and both companies' stock surged, selling several dollars above even that top price.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription